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Abstract
Background: Among the naturally occurring compounds, turmeric from the dried rhizome of the
plant Curcuma longa has long been used extensively as a condiment and a household remedy all over
Southeast Asia. Turmeric contains essential oil, yellow pigments (curcuminoids), starch and
oleoresin. The present study was designed for investigating the neuroprotective efficacy and the
time window for effective therapeutic use of Curcuma oil (C. oil).
Method: In the present study, the effect of post ischemic treatment of C.oil after ischemia induced
by occlusion of the middle cerebral artery in the rat was observed. C.oil (500 mg/kg body wt) was
given 4 hrs post ischemia. The significant effect on lesion size as visualized by using diffusion-
weighted magnetic resonance imaging and neuroscore was still evident when treatment was started
4 hours after insult. Animals were assessed for behavioral deficit scores after 5 and 24 hours of
ischemia. Subsequently, the rats were sacrificed for evaluation of infarct and edema volumes and
other parameters.
Results: C.oil ameliorated the ischemia induced neurological functional deficits and the infarct and
edema volumes measured after 5 and 24 hrs of ischemia. After 24 hrs, immunohistochemical and
Western blot analysis demonstrated that the expression of iNOS, cytochrome c and Bax/Bcl-2
were altered after the insult, and antagonized by treatment with C.oil. C.oil significantly reduced
nitrosative stress, tended to correct the decreased mitochondrial membrane potential, and also
affected caspase-3 activation finally apoptosis.
Conclusion: Here we demonstrated that iNOS-derived NO produced during ischemic injury was
crucial for the up-regulation of ischemic injury targets. C.oil down-regulates these targets this
coincided with an increased survival rate of neurons.
Background
Curcuma longa Linn, commonly known as turmeric, is a
perennial plant belonging to the family Zingiberaceae.
This common Indian dietary spice and pigment has had a
prominent place in the armentarium in the traditional
Indian medicine. The active constituents of turmeric are
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categorized into the non-volatile components curcumin
and other curcuminoids and the volatile curcuma oil. The
content of the curcuma oil are the turmerones and other
sesquiterpenoid cyclic ketones [1]. The highly lipophilic
nature of the Curcuma oil may have as it is reported to
have access to the brain after stroke through the transcel-
lular lipophilic pathway. C.oil has been reported in scien-
tific literature for antimicrobial, antifungal, antiviral [2],
anti-inflammatory activities, wound healing, insecticidal
activity [3] and, of late, for its potent effect in oral sub-
mucosal fibrosis in human [4].
The chemical components in oil extracted from the rhi-
zome of Curcuma longa after identification of the chemical
constituents with the help of GC, GC-MS are recently
reported [5]. The standardization of C.oil was carried out
by using HPLC. Sesquiterpenoids are the major constitu-
ents of turmeric oil and ar-turmerone is the major tur-
merone, identified by GC-MS analysis. We have recently
reported the beneficial antioxidant effects of pretreatment
by C.oil in the filament model of middle cerebral artery
occlusion rat [6], this model of focal ischemia has been
associated with generation of free radicals [7]. Cerebral
ischemia is associated with enhanced oxidative and nitro-
sative stress. A substantial proportion of cell death after
brain ischemia results directly or indirectly from oxida-
tive/nitrosative injury. In our another recent report on
neuroprotective effect of the pretreatment of C.oil in fila-
ment model of middle cerebral artery occlusion, is due to
attenuation of oxidative/nitrosative stress [8].
In the clinical scenario, the time point at which medical
intervention becomes available is very critical. Most of the
studies in the past were carried out by pretreatment of test
agents. This is not a promising approach in the clinical
scenario. This is evident from the finding that in the first
hour of reperfusion after two hours of occlusion of the
middle cerebral artery (MCAo), the bioenergetics state of
the tissue is extensively restored, but secondary deteriora-
tion is observed after 4 hrs of recovery and thereafter [9].
Expression of inducible nitric oxide synthase (iNOS)
occurs in the later stage of cerebral ischemia, and NO pro-
duced by iNOS contributes to delays in recovery from
brain neuronal damage.
While there are many reasons why experimental neuro-
protection has been difficult to replicate in patients, one
major area is appropriateness of the animal models used.
It has been suggested that the embolic stroke model
encompassing a more 'physiological' spontaneous reper-
fusion process, more akin to the clinical pathology, and
with a low mortality rate and excellent reproducibility
[10] would be more predictive. The other reason for using
the embolic stroke model is on the basis of recommenda-
tions of the "Stroke Therapy Academic Industry Roundta-
ble" which have specifically recommended particularly
that preclinical neuroprotective activity for cerebral
ischemia should be tested in multiple cerebral ischemia
models in order to get the ideal neuroprotective agent
[11,12].
Another important point of surviving stroke patients is
disability and dependence because of functional impair-
ment. In clinical studies, functional outcome after an
ischemic episode is one of the most useful parameters. We
associated in the present study evaluation of functional
outcome (neurological deficit score) with lesion size
along with progression of infarct. For this region all
parameters were studies after 24 hrs of ischemia when sig-
nificant neurological deficits were observed. In this study,
we explore the effects of post-ischemic treatment by C.oil
in an embolic stroke model in the rat for its neuroprotec-
tive efficacy and therapeutic window. Prior to the present
study a good correlation between concentration of major
constituents by HPLC and GC of C.oil was done [5].
Methods
Experimental Procedure
Animals
Male Sprague Dawley rats (maintained at the Animal
House facility of the Central Drug Research Institute at
Lucknow) were used in the present study. All animal
experiments were carried out in strict accordance with the
Institute guidelines on the care and use of experimental
animals. Rats were fasted overnight (12 hrs–16 hrs) with
free access to water before surgery.
Extraction of C.oil
Curcuma oil isolation: After botanical identification sam-
ple of the dried rhizomes of Curcuma longa of Zingiber-
aceae family were preserved by the Botany department of
the Central Drug Research Institute, India, for future refer-
ence. Rhizomes were powered and extracted at room tem-
perature with light petroleum ether. The extract was
concentrated at low temperature to remove petroleum
ether; the oily residue was collected and dried. The identi-
fication of chemical constituents present in C.oil was
done with GC, GC-MS. The standardization of C.oil was
done using HPLC method and a mixture of a group of ter-
penoids were isolated and identified. The chemical profile
of curcuma oil was done with GC-MS. It is a pale yellow
to orange yellow odoriferous oil. Recently Raina et al.,
(2002) reported that curcuma oil comprised of 100% of
oil and contained 84 constituents [13].
Major constituents of curcuma oil were ar-turmerone, α-β
turmerone, and curlone (Fig. 1). Four major curcumenes:
curcumene, zingiberene, bisabolene and sesquiphelland-
rene and other minor constituents like zederone, germa-
crone, curdione, curcumerone, zederondiol andBMC Complementary and Alternative Medicine 2008, 8:55 http://www.biomedcentral.com/1472-6882/8/55
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isozederendiol and three curcuminoids: mono-demeth-
oxy curcumin, di-demethoxy curcumin, curcumin were
identified. The stability with change in pH and other
physiochemical properties like photosensitivity etc has
been published recently [5,14]. C.oil was given 500 mg/kg
and three marker compounds ar-turmerone, α-β tur-
merone and curlone were selected for plasma concentra-
tion time profile. The Cmax  (ng/ml) for ar-turmerone
turmerones, α-β turmerone and curlone was 412 ± 97.4,
316 ± 129.7 and 21.4 ± 6.6 respectively and Tmax was 2 hrs
(unpublished observation).
Experimental groups
All the animal were neurologically evaluated before the
start of experiments and any rat showing any deficit were
not included in the study.
Following groups of five rats were assigned. (A) Sham-
operated rat euthanized at 5 and 24 hrs for quantification
of edema and infarct volumes and other parameters; (B)
peanut oil treatment 4 hrs after ischemia and evaluation
was done 5 hr for Diffusion-Weighted Magnetic Reso-
nance Imaging (DW-MRI). (C) Peanut oil or curcuma oil
treatment was given at 4 hrs after ischemia. After 1 hr of
treatment evaluation was done for neurological scores.
Thereafter rats were euthanized for quantification of
edema and infarct volumes (D) Peanut oil or Curcuma oil
was given at 4 hrs after ischemia. After 6, 12 and 24 hrs of
ischemia brain tissue nitrate/nitrite levels were estimated.
For sham-operated no treatment was given. (E) Peanut oil
or Curcuma oil was given 4 hrs after ischemia and neuro-
logical evaluation were made after 24 hrs of ischemia.
Thereafter rats were euthanized for quantification of
edema and infarct volumes and other parameters.
To run a parallel control, rats from ischemic group were
given commercially available peanut oil in equal volume.
In our preliminary experiments, peanut oil and normal
saline were used as control treatments and the behavioral
data did not differ between the rats that received the two
vehicle solutions [15]. Therefore, we chose to present only
the peanut oil control group data for comparison.
The dose of C.oil was chosen according to the pharmacok-
inetic properties of C.oil in experimental animals (data
not shown) as well as our dose response experiments. The
C.oil 500 mg/kg was administered after 4 hrs of clot
implant via the oral route as such to rats and no vehicle
was used in the study. The reason for oral route delivery
was based on the earlier published report of [5] that the
oil was most effective in the treatment of bronchial
asthma by oral route than when given intramuscularly.
To rule out the possibility of spontaneous re-canalization
before C.oil treatment, whether the attenuation that was
observed in the C.oil treated animals was due to the treat-
ment, and not because of the reperfusion effect prior to
treatment, it was very important to demonstrate that all
animals had equivalent ischemic state (i.e. before treat-
ment). For this reason Diffusion-Weighted Magnetic Res-
onance Imaging (DW-MRI) recordings were taken from
each rat before and after ischemia and again after C.oil
treatment in treated rats. The same protocol was followed
for the peanut oil treated ischemic and sham-operated
rats. All the untreated rats were firstly scanned for DW-
MRI and any rat showing any significant lesion was
excluded from the study. The same rats were evaluated for
neurological deficit after 24 hrs of ischemia. Thereafter
these rats were euthanized and post mortem brain infarcts
and edema volumes were determined. For the rest of
experiments, separate group of rats were used and evalua-
tions were made 24 hrs after ischemia.
Focal Embolic Model
To induce reproducible lesions obstructions by emboli
should be in the proximal segment of a large feeder artery
[16]. Embolic cerebral ischemia was induced as reported
earlier by injecting multiple fibrin-rich autologous clots
one after another into the external carotid artery [16,17].
For clot formation blood was drawn from the femoral
vein of a donor rat and left to form a clot as reported [16].
The clot was fragmented by extruding it twice through a
27-gauge needle and washed. Multiple fibrin-rich autolo-
gous clots formed in this way.
Briefly, for producing embolic cerebral ischemia rats were
anaesthetized with chloral hydrate (400 mg/kg, i.p.). The
right common carotid artery (CCA), the right internal
carotid artery (ICA) and the right external carotid artery
(ECA) were exposed by a ventral incision in throat. The
The chemical structures of the major constituents obtained  from Curcuma oil ar-turmerone; turmerone; curlone; Zin- giberene and Curcumene Figure 1
The chemical structures of the major constituents 
obtained from Curcuma oil ar-turmerone; tur-
merone; curlone; Zingiberene and Curcumene.BMC Complementary and Alternative Medicine 2008, 8:55 http://www.biomedcentral.com/1472-6882/8/55
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multiple clots suspended in phosphate with phosphate-
buffered saline (0.3 ml) were taken up in a Hamilton
syringe connected to a PE 50 catheter. The tip of the cath-
eter was advanced up to 17 mm into the internal carotid
artery via the stump of the external carotid artery and the
clot were lodge into the MCA stem during which time the
common carotid artery was temporarily closed. Selection
of appropriate clot and by washing results to high fibrin
content of clots ensures durability and delays the sponta-
neous lysis. After removal of the catheter, the clips on the
right CCA and the right ECA were removed and the inci-
sion was closed. The sham-operated rats underwent same
surgical procedure and a PE 50 catheter was advanced up
to 17 mm in the ICA via ECA and immediately withdrawn
without leaving behind a clot implant. The rectal temper-
ature in the animals was kept at 37°C throughout the sur-
gical procedure with the help of heating pad.
Early detection of lesion area using diffusion-weighted MRI (DW-
MRI)
MRI was used to examine ischemic rat brain after 1 hr of
C.oil treatment. The DW-MRI scan was taken from same
rat, before, after ischemia and again about 1 hr after C.oil
or peanut oil treatment. All DW-MRI experiments were
carried out according to Rathore et al (2008)[6], using an
animal MRI/MRI scanner (Bruker, BIOSPEC). A 69-mm
circularly polarized birdcage volume resonator was used
to carry out experiments at 4.7 T. The seven slices acquired
were summed to provide the total volume of ischemic
injury. The threshold value of 15% was found to be the
lowest cutoff value that did not include pixels in the con-
tra lateral non ischemic hemisphere [18]. Result of seven
coronal sections each brain of five rats per group is given.
Neurological Evaluation
After 5 hrs and 24 hrs of DW-MRI evaluation the rats from
sham-operated, peanut oil and C.oil post treated groups
were evaluated for neurological deficit. An observer who
was unaware of the identity of the groups assessed neuro-
logical deficits and gained scored as described by the
[19,20] ; as follows: 0–no observable neurological deficit
(normal); 1–failure to extend left forepaw on lifting the
whole body by tail (mild); 2–circling to the contralateral
side (moderate); 3–leaning to the contralateral side at rest
or no spontaneous motor activity (severe). Result of neu-
rological deficit evaluation were made from ten rats/
group and expressed as median/range.
Determination of cerebral infarct and edema
The further study was planned to correlate the lesion
assessed in vivo by DW-MRI and infarct and edema vol-
umes. The rational of this study was that the change in
lesion volume at the early stage of stroke on total evolu-
tion of thromboembolic stroke, because recent therapy in
acute stroke is based on reperfusion of the ischemic legion
leading to salvage of the ischemic penumbra, smaller inf-
arct size, and improved outcome [21].
Rats from all the groups that were initially evaluated for
DW-MRI at 5 hrs and 24 hrs and thereafter evaluated for
neurological deficits. The rats were euthanized and the
brains were quickly removed and cooled on ice for a few
min and then coronally sectioned by a tissue slicer in 2-
mm thick sections starting from 2 mm caudal to the fron-
tal tip. Each slice was examined for subarachnoid hemor-
rhage. The slices were immediately stained with 1% 2, 3,
5-triphenyltetrazolium chloride (TTC) (Sigma) at 37°C
for 15 min and fixed immersion in 4% phosphate-buff-
ered formalin solution [20,22]. The infarct area and
edema volume in seven coronal sections of each brain was
determined using the scanned image with a CCD camera
(Samsung, Korea) and quantified with Biovis, Expert
vision, (India). The total infarct volume was determined
by summing up the infarct areas of the seven sections
which was multiplied by thickness of brain sections (2
mm) to get the volume of infarction and was corrected for
edema volume. Edema correction of infarct volume was
done using the equation, volume correction = (infarct vol-
ume × contra lateral volume)/ipsilateral volume. The vol-
umes of both the contra lateral and the ipsilateral
hemispheres were calculated from the product of the aver-
age slice thickness (2 mm) and the sum of areas in all
seven brain slices, and edema volume was calculated by
subtracting the contralateral volume from the ipsilateral
volume.
Measurements of nitrate and nitrite levels
The final products of NO in vivo are nitrate and nitrite,
and thus the sum of both species is an index of total NO
production [23]. Nitrate and nitrite content was estimated
at 6, 12 and 24 hrs after ischemia. Rats from sham-oper-
ated, peanut oil treated ischemic and C.oil treated rats
were euthanized at 6, 12 and 24 hrs. Briefly, animals were
euthanized and the brains were quickly removed. Ipsilat-
eral sides of forebrain from each group were homoge-
nized in 3 volumes (w/v) of PBS (pH 7.4) at 4°C.
Homogenates were then sonicated and centrifuged at
100,000  g  for 60 min at 4°C. The nitrate plus nitrite
(NOx) values were determined in the supernatants using
a colorimetric kit according to the manufacturer's instruc-
tions (Nitrate/Nitrite colorimetric assay kit, Cayman
Chemical) by a simple two-step process. The first step was
the conversion of nitrate to nitrite utilizing nitrate reduct-
ase and NADPH at room temperature for 3 hrs. The sec-
ond step was the measurement of nitrite content by the
Griess reaction, by adding 100 μl of Griess reagent to 100
μl of samples. Griess reagent converts nitrite into a deep
purple azo compound. Photometric measurement of the
absorbance at 550 nm due to this azo chromophore using
ELISA micro plate reader (Power wave XS, BIO-TEK,BMC Complementary and Alternative Medicine 2008, 8:55 http://www.biomedcentral.com/1472-6882/8/55
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U.S.A.) accurately determines NO2
- concentration. Nitrite
concentration was calculated by comparison with OD550
of standard nitrite solution [24]. Results are expressed as
μmol/mg protein.
Myeloperoxidase estimation
Myeloperoxidase (MPO) activity, an indicator of poly-
morphonuclear leukocyte (PMN) accumulation, was
determined as previously described [25]. Rats from sham-
operated, peanut oil treated ischemic and C.oil treated
rats were euthanized after 24 hrs of ischemia and MPO
activity was estimated. Briefly, ipsilateral side of forebrain
were homogenized (Polytron, three times at 5-second
bursts) in 20 times the volume of 5 mmol/L phosphate
buffer (pH 6.0) at 4°C, followed by centrifugation at
30,000 g for 30 minutes at 4°C. The supernatant was dis-
carded, and the pellets were extracted by suspending in 10
times the volume of 0.5% hexadecyl trimethyl ammo-
nium bromide in 50 mmol/L phosphate buffer (pH 6.0)
at 25°C. These samples then were frozen on ice, with
three freeze/thaw cycles, and sonicated for 10 seconds at
25°C. After sonication, the samples were incubated for 20
minutes at 4°C and centrifuged at 12,500 g for 15 minutes
at 4°C. MPO activity in the supernatant was assayed
reported earlier by us [22].
Tissue caspase-3 and caspase-1& 4 estimation
The fluorometric substrate Ac-DEVD-AMC and Ac-YVAD-
AMC were used for the determination of caspase-3 and
caspase-1&4 activities. Caspase 1&4 estimation was made
24 hrs after ischemia. Rats from sham-operated, peanut
oil treated ischemic and C.oil treated rats were euthanized
after 24 hrs. Ipsilateral side of forebrains were quickly iso-
lated, washed with phosphate buffered saline and cells
lysed in 20 mM Tris HCl buffer (pH 7.4) containing 150
mM NaCl, 1 mM dTT, 5 mM EDTA, 5 mM EGTA and 1%
w/v Triton X-100. Tissue lysate was obtained by centrifu-
gation at 100,000 g for 30 min. Cleared lysate containing
50–100 μg of protein was assayed with 100 μM of the
enzyme substrate Ac-DEVD-AMC and Ac-YVAD-AMC in
assay buffer (100 mM Hepes, 10% glycerol, 1 mM EDTA,
10 mM dTT) and incubated for 60 minutes at 37°C.
Absorbance of the cleaved product was measured using a
Fluorimeter (Varian Cary Eclipse) with excitation at 380
nm and emission at 460 nm and the activity was
expressed as percent of substrate released over control.
Flowcytometric estimation of nitric oxide (NO), reactive 
oxygen species (ROS) intracellular calcium level (Ca++), 
peroxynitrite (ONOO-), and mitochondrial membrane 
potential (ΔΨm)
Estimations were done after 24 hrs of ischemia. Rats from
sham-operated, peanut oil treated ischemic and C.oil
treated rats were euthanized after 24 hrs and brains were
quickly removed. For neuron isolation the forebrain of
ipsilateral side was dissected and processed according to
the method detailed by Rathore et al (2008), Dohare et al
(2008) [6,20] and Rastogi et al (2006) [22]. In neuronal
rich cell population were used for the estimation of ROS,
NO, ONOO-, mitochondrial membrane potential
(ΔΨm), intracellular calcium level (Ca++) and quantifica-
tion of cell death type. A homogenous suspension of indi-
vidual neurons was prepared in PBS, (pH 7.4) by
treatment of finely chopped forebrain tissue with dispase
(1000 protease unit/ml) for 45 min at 37°C. After enzy-
matic treatment, the dissociated neurons were passed
through a filter (~53 μm) to remove large neurons and tis-
sue fragments as reported by us [6,20]. Confirmation of
neuron population was done by labeling the neurons
with NeuN (a monoclonal antibody against neuron-spe-
cific marker NeuN conjugated with PE; SC7301, San-
tacruz; dilution 1:50). NeuN positive neurons were gated
in the dot plot and the same gating was used in the entire
study. Fluorescence was determined in a flowcytometer
(Becton Dickinson, UK, Ltd). Data were analyzed using
Cell Quest Software (Becton Dickinson UK, Ltd). For each
sample, 10,000 neurons (events) were acquired. The flow-
cytometry data was expressed as mean ± S.E.M. from five
animals per group of each rat brain.
Nitric oxide measurement
For NO estimation, isolated neurons (106/ml) were incu-
bated with Diaminofluorescein diacetate (DAF-2DA) (10
μM) for 30 min at 37°C. Fluorescence was measured at an
excitation wavelength of 495 nm and emission wave-
length of 515 nm [26].
Reactive oxygen species measurement
ROS was measured with the help of 2', 7'dichlorodihy-
drofluorescein diacetate (DCDHF-DA). Isolated neurons
(106/ml) were incubated with 50 μM of DCDHF-DA for
30 min at 37°C. Fluorescence was measured at an excita-
tion wavelength of 488 nm and emission wavelength of
530 nm [6].
Intracellular calcium measurement
For measurements of intracellular calcium the neurons
were washed twice with PBS without calcium and magne-
sium. After washing, the cells were re-suspended at 2 × 106
cells/ml in PBS and incubated for 30 min at 37°C with
100 μg/ml Pluronic F-127 and 7.5 μM of the fluorescent
calcium probe Fluo-3AM. After incubation, the cells were
washed twice with PBS. Fluorescence was measured at
excitation wavelength of 506 nm and emission wave-
length of 526 nm [27].
Peroxynitrite measurement
The direct reaction of DHR 123 with H2O2 does not occur
but can be catalyzed by heme-containing peroxidases.
Neurons were loaded with DHR 123 and it was necessaryBMC Complementary and Alternative Medicine 2008, 8:55 http://www.biomedcentral.com/1472-6882/8/55
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to check the genuineness of the signals obtained. SOD
diminishes the signals due to peroxynitrie while CAT
which reacts with H2O2 should not. We did the pilot
experiments and have reported in our recent paper [8].
The formation of ONOO- was measured by the ONOO-
dependent oxidation of dihydrorhodamine-123 (DHR-
123). Isolated neurons (106/ml) were incubated with 5
μM DHR-123 for 60 minutes at 37°C. After incubation,
123-DHR conversion to 123-rhodamine was measured at
excitation wavelengths of 500 nm and emission wave-
length of 536 nm [28].
Mitochondrial membrane potential (ΔΨm) measurement
The mitochondrial membrane potential (ΔΨm) was
measured by the retention of Rhodamine 123, a cationic
dye, which accumulates electrophoretically into energized
mitochondria in response to their negative inside mem-
brane potential. Neurons (106/ml) were loaded with Rhd
123 (1.3 μM) for 30 min [29].
Neuronal death measurement
For quantification of mode of neuronal death neurons
isolated were labeled with FITC (Fluorescene Iso thio-
cyanate) conjugated Annexin V and Propidium iodide
(PI). Loading of fluorochromes was done according to the
manufacturer's protocol (Calbiochem, Apoptosis Detec-
tion kit). In brief, after incubation at room temperature
for 15 min in the dark, the cells were analyzed by FACScan
analyzer at an excitation wavelength of 488 nm and emis-
sion wavelength of 530 and 670 nm. When the two fluor-
ochromes were used simultaneously, the dead PI positive
cells fall in the upper left quadrant, the apoptotic
Annexin-V FITC positive cells in the lower right quadrant,
viable neurons negative for both of these stains fall in the
lower left quadrant. Late apoptotic/necrotic which were
positive for both PI and Annexin-V FITC fall in upper right
quadrant [6,8,22].
Immunohistochemical analysis of iNOS, eNOS and 
cytochrome c expression
Expression of iNOS, eNOS and cytochrome c were esti-
mated 24 hrs after ischemia in brain cryosections from
each brain of five rats/group. Rats from sham-operated,
peanut oil treated ischemic and C.oil treated rats were
euthanized 24 hrs after ischemia. Expression of iNOS,
eNOS and cytochrome c were detected in the cryosections
by immunohistochemical analysis using highly specific
antibodies [30]. In brief, brains were placed on frozen sec-
tion medium Neg50 (Richard-Allan Scientific) for cryostat
sections. Six micrometer-thick sections were cut by a cryo-
stat (Microm HM 550) and mounted on slides coated
with poly L-lysine (0.1% w/v in water). A maximum of
five slides per brain, with several sections on each slide, in
a pre-selected region of interest were taken. Brain sections
at roughly the same coronal level, approximately 2.8 mm
posterior to the bregma, containing the dorsal hippocam-
pus, corpus callosum and thalamus were chosen. These
brain tissue sections were first fixed in 4% paraformalde-
hyde for 1 hr and then after washing in 0.1% glycine PBS
(Phosphate buffered saline, pH 7.4) were used for
quenching. Sections were than permeabilized with 0.1%
Triton X-100 for 10 minutes. Sections were washed with
PBS and blocked in blocking buffer (0.5%BSA in PBS) for
1 hr to reduce non-specific staining. Sections were incu-
bated overnight with primary polyclonal iNOS antibody
conjugated with FITC (SC-651; Santacruz, 1:200) primary
antibody for eNOS (SC-653; Santacruz, 1:200) and cyto-
chrome c (SC-7159; Santacruz, 1:200), diluted in block-
ing buffer to 1:200 ratio and then rinsed 5 times for 5 min
each time in PBS. After washing, sections were treated
with DAPI (300 nM) for counterstaining for 5 min at
room temperature and again washed 5 times for 5 min
and then the sections were incubated with secondary anti-
rabbit polyclonal antibody conjugated with FITC (Santa
Cruz Biotechnology, USA), diluted in blocking buffer to
1:400 ratio for 4 hrs. After washing, sections were
mounted in 90% glycerol with anti-fading agent (PPD).
All the sections were analyzed using IM 50 software in a
Leica D2LB microscope and images from the same cortical
region were captured with the associated software. Images
were further processed using Photoshop software (Adobe,
San Jose, CA). For negative control only the primary anti-
bodies were omitted.
Expression of iNOS, eNOS, cytochrome c, Bax and Bcl-2 
by Western Blot
Western blot analysis of iNOS, eNOS, cytochrome c, Bax
and Bcl-2 expression in the forebrains of the rats was car-
ried out after 24 hrs of ischemia. Rats from sham-oper-
ated, peanut oil treated ischemic and C.oil treated groups
were euthanized after 24 hrs of ischemia. Five rats/group
were used for the study. Ipsilateral side of forebrain was
dissected and homogenized at 4°C in a Tris-HCL buffer
(50 mM, pH 7.6) containing: 150 mM KCL, 5 mM ethyl-
enediamine tetraacetic acid (EDTA), 1 mM phenylmeth-
ane sulfonylfluoride (PMSF), 1% Triton X-100, 0.5 μg/mL
leupeptin and 1 μg/mL pepstatin [30]. The homogenate
was centrifuged at 15,000 g for 20 min and the superna-
tant used as the cytosolic fraction. Total cellular proteins
(50 μg/lane cytosolic fractions) were separated on a 10%
SDS-polyacrylamide gel and electro-transferred onto
PVDF membranes (Hybond ECL, Amersham Interna-
tional, Bucks, U.K.). Equal loading and transfer of pro-
teins was confirmed by temporally staining the
membranes with Ponceau S solution. Nonspecific bind-
ing of proteins was prevented by treating the membranes
with 5% nonfat dry milk in Tris-buffered saline/0.1%
Tween 20 for 2 hrs at room temperature. The membranes
were incubated overnight at 4°C with anti iNOS (1:1000;
Santacruz), anti eNOS (1:1000; Santacruz), anti cyto-BMC Complementary and Alternative Medicine 2008, 8:55 http://www.biomedcentral.com/1472-6882/8/55
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chrome c (1:500; Santacruz), anti-Bax (1:500; Oncogene)
and anti-Bcl-2 antibody (1:500; Oncogene). After incuba-
tion with secondary antibody conjugated to horseradish
peroxidase (anti-rabbit, 1:20000; Santacruz), immunore-
active proteins were detected by the enhanced chemilumi-
nescence's system (ECL, Sigma) and serial exposures were
made to radiographic film (Hyper film ECL, Amersham
International).
Protein estimation
Protein content of the supernatant was determined using
bovine serum albumin (BSA fraction V, Sigma) as the pro-
tein standard by the method of Lowry et al (1951) [31].
Chemicals/Reagents used
Ac-DEVD-AMC, Ac-YVAD-AMC, bovine serum albumin,
dispase, dithiothreitol, 2', 7'dichlorodihydrofluorescein
diacetate, dihydrorodamine-123, diaminofluorescein dia-
cetate, ethylenediamine tetraacetic acid, ethyleneglycol-
bis-(β-aminoethyl ether) N,N,N'N'-Tetraacetic acid, Fluo-
3AM, Glycine, Glycerol, hexadecyl trimethyl ammonium
bromide, leupeptin, O-Dianisidine-HCl, paraformalde-
hyde, pepstatin, phenylmethane sulfonylfluoride,
Pluronic F-127, ponceau S, propidium iodide, sodium
azide, sodium dodecyl sulphate, Tris-HCl, Triton X-100,
tween 20, triphenyltetrazolium Chloride and enhanced
chemiluminescence system were procured from Sigma
Chemical Co., St. Louis MO, USA). PVDF membrane and
Hyperfilm ECL were procured from Amersham Interna-
tional (Bucks, U.K.). Primary and secondary antibodies
were purchased from Santacruz (California, USA) and
Oncogene (CA, USA). Nitrate/Nitrite colorimetric meas-
urement kit was from Alexis (CA, USA), and Apoptosis
Detection kit was from Calbiochem (Germany). Other
chemicals of AR grade were obtained from SRL and Qua-
ligens, India.
Statistical analysis
All values (except neurological deficits) in the figures are
expressed as means ± standard error of the mean (S.E.M.).
The results were analyzed by One-way analysis of variance
(ANOVA) with post hoc comparison (Newman Keuls
multiple) test as per nature of data. For neurological defi-
cit scores, the nonparametric data were analyzed by
Kruskal Wallis test followed by Dunn's multiple compari-
son test. P-value of less than 0.05 was considered signifi-
cant. All the analyses were performed with Graph Pad
prism software (Ver. 3.03).
Results
Lesion volume analysis by MRI studies
Diffusion-weighted Magnetic resonance Imaging (DWI) is
very sensitive as it can detect ischemic lesions in the
hyperacute phase of ischemia even within minutes of
injury [32]. The greater the neuronal damage the brighter
the DWI lesion, [33]. After 3 hrs of ischemia, rats showed
significant increase in the lesion area in the ischemic hem-
isphere (207.4 ± 10.2 arbitrary units). The significant
effect on lesion size and neuroscore was still evident when
treatment of C.oil was started 4 hours after insult. The sig-
nal intensity in the ischemic hemisphere after C.oil treat-
ment was 176.7 ± 14.78 as compared to its ischemic value
(before the treatment). C.oil or peanut oil was given after
4 hrs of ischemia the animals were again scanned after 1
hour. In the peanut oil post treated group, the difference
in the signal intensity of the ischemic hemisphere was not
statistically significant as compared to its previous scans
(Fig. 2 Upper panel and d). These observations rule out
the possibility of spontaneous re-canalization before C.oil
treatment. The DW-MRI data show that the neuroprotec-
tive effect of C.oil was observed as early as 1 hour post oral
treatment with the oil. Since the animals treated with pea-
nut oil not show any reduction in the signal intensity after
treatment and the group treated with C.oil did show sig-
nificant reduction in intensity, a reasonable conclusion
would be that the effect seen in the C.oil treated group
would be due to the C.oil and not due to spontaneous
reperfusion.
Neurological deficits
After 5 hrs of ischemia in the peanut oil treatment rats the
neurological scores were significantly increased (median
1.7) as compared to sham-operated rats. Post ischemic
treatment with C.oil failed to offer significant reduction
(median 1.3) in the neurological scores after 1 hr of treat-
ment as compared to ischemic peanut oil treated rats (Fig.
3d).
After 24 hrs of ischemia, the neurological scores were sig-
nificantly (median 2.9) effected by ischemic peanut oil
treated rats. C.oil could significant improve the neurolog-
ical deficit induced by ischemia (median 1.2; P < 0.05)
(Fig. 4d).
Infarct and brain edema volume
At 5 hrs corrected infarct volume in the peanut oil treated
ischemic rats (n = 5) was 148.0 ± 19.36 mm3. Treatment
with C.oil post ischemia produced decrease in the infarct
volume to 66.00 ± 14.39 mm3, P < 0.001 as compared to
the peanut oil treated ischemic group (Fig. 3 Upper panel
and e). Edema volume in the peanut oil treated ischemic
animals at 5 hrs (n = 5) was 48.23 ± 6.36 mm3 signifi-
cantly increase as compared to sham-operated and C.oil
post treatment. C.oil treatment decreased the edema vol-
ume to 26.36 ± 5.367.64 mm3, P < 0.001 (Fig. 3f).
At 24 hrs corrected infarct volume in the peanut oil treated
ischemic rats (n = 10) was 225.32 ± 16.25 mm3. Treat-
ment with C.oil post ischemia produced decrease in the
infarct volume to 92.23 ± 15.69 mm3, P < 0.001 as com-BMC Complementary and Alternative Medicine 2008, 8:55 http://www.biomedcentral.com/1472-6882/8/55
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pared to the peanut oil treated ischemic group (Fig. 4
Upper panel and e). Edema volume in the peanut oil
treated ischemic animals (n = 10) was 98.36 ± 15.23 mm3
significantly increase as compared to sham-operated and
C.oil post treatment. C.oil treatment decreased the edema
volume to 41.21 ± 15.69 mm3, P < 0.01 (Fig. 4f). None of
the C.oil treated rat brain during isolation showed any
signs of sub-arachnoid hemorrhage.
Nitrate/nitrite levels
In the peanut oil treated ischemic rats no significant
increase in the nitrate as well as nitrite level was observed
at 6 and 12 hrs.(Fig. 5a and 5b) After 24 hrs post ischemia
a significant increase (P  < 0.001) in both nitrate and
nitrite levels were observed in peanut oil treated rats. C.oil
treatment significant decrease (P < 0.01) this ischemia
induced increase in both nitrate and nitrite levels after 24
hrs post ischemia (Fig. 5a and 5b).
Myeloperoxidase activity
The accumulation of neutrophils was investigated by
measuring MPO activity from peanut oil treated animals
after 24 hrs. MPO levels in the peanut oil treated ischemic
brain tissue were estimated to be 175 ± 5 mU/g/min, sig-
nificantly higher as compared to the sham-operated
group; 65 ± 5 mU/g/min. C.oil post treatment signifi-
cantly reduced the MPO activity to 126 ± 5.09 mU/g/min
(P < 0.001) (Fig. 5c).
Caspase-3 and caspase-1&4 enzymatic activities
Ischemia induced a significant increase in mean fluores-
cence obtained from the caspase-3 and caspase-1&4 activ-
Effect of C.oil post-treatment on lesion area of brain at 5 hrs Figure 2
Effect of C.oil post-treatment on lesion area of brain at 5 hrs. The MRI scan was taken from same rat, before, after 
ischemia and 1 hr after peanut oil treatment- the ischemic group. In the second set of rats MRI scan was taken before and after 
ischemia and again after 1 hr of C.oil treatment. Hyper intense areas represent the lesion. Upper panel shows the representa-
tive photograph of brain scan from brains of sham-operated (a), 5 hrs after rat treated with peanut oil (b) and 5 hrs after rat 
treated with C.oil (c). Bar graph (d): The bar chart showing the lesion area of brains of sham-operated, peanut oil treated 
ischemic and C.oil post-treatment ischemic group at 5 hrs. Data are expressed as mean ± S.E.M. P < 0.001 was considered 
highly significant when comparisons were made with the peanut oil treated ischemic group by one way ANOVA followed by 
Newman Keuls post hoc test. Data are from five rats per group.BMC Complementary and Alternative Medicine 2008, 8:55 http://www.biomedcentral.com/1472-6882/8/55
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ities when compared with sham-operated. C.oil treatment
significantly reduced the ischemia induced increase in cas-
pase-3 (P < 0.05) and caspase-1&4 (P < 0.001) activities
(Fig. 5d and 5e).
Flowcytometric estimations
A neuronal rich cell suspension was prepared from the
forebrain of sham-operated, I/R and C.oil treated group of
rat after 24 hrs of reflow. The viability of neurons was con-
firmed by using Apoptosis Detection kit (detailed below).
Neurons were labeled with Annexin V conjugated with
Protective effect of C.oil on brain infarct and edema volumes and neurological evaluation from rat subjected to middle cerebral  artery occlusion at 5 hrs Figure 3
Protective effect of C.oil on brain infarct and edema volumes and neurological evaluation from rat subjected 
to middle cerebral artery occlusion at 5 hrs.Upper panel showing the representative photograph of TTC stained coronal 
brain section after 5 hrs of ischemia from sham-operated (a), peanut oil treated ischemic (b) and ischemia with C.oil post-treat-
ment (c) group at 5 hrs. Unstained areas represent the infarcted brain tissue. Bar graph (d): Neurological evaluation scores of 
rats from sham-operated, peanut oil treated ischemic and C.oil post-treatment ischemic groups after 5 hrs of ischemia as 
shown in scattergram. The line demarcates the median. Comparisons were made between C.oil post treated vs. peanut oil 
treated ischemic group by nonparametric Kruskal-Wallis test followed by Dunn's Multiple Comparison Test. Ten rats/group 
was used. Bar graph (e): The bar chart showing the infarct volume of brains from sham-operated, peanut oil treated ischemic 
and C.oil post-treatment ischemic. Data are expressed as mean ± S.E.M. P < 0.001 was considered highly significant when com-
parisons were made with the peanut oil treated ischemic group by one way ANOVA followed by Newman Keuls post hoc test. 
Bar graph (f): Effect of post-treatment of C.oil on edema volume after 5 hrs of ischemia. Data are expressed as mean ± S.E.M. 
of five animals each group. P < 0.001 was considered significant when comparisons were made with the peanut oil treated 
ischemic group by one way ANOVA followed by Newman Keuls post hoc test.BMC Complementary and Alternative Medicine 2008, 8:55 http://www.biomedcentral.com/1472-6882/8/55
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FITC which labels the phosphotidylserine sites on the
membrane surface of the apoptotic cells and Propidium
iodide (PI) to label the cellular DNA in necrotic cells. The
Neuronal rich cell population from sham-operated rats
was negative for both of these stains confirming that these
neurons were viable (Fig. 6 lower panel f).
Nitric oxide measurement
Significantly increased level of NO was observed in pea-
nut oil treated group as compared to sham-operated ani-
mals. C.oil post-ischemic treatment showed significant
decrease in NO content (P < 0.01) (Fig. 6a).
Effect of C.oil given 4 hrs after ischemia and evaluation were made after 24 hrs of ischemia Figure 4
Effect of C.oil given 4 hrs after ischemia and evaluation were made after 24 hrs of ischemia. After 24 hrs sham-
operated, peanut oil treated ischemic group and C.oil post treated group of rats were evaluated for neurological deficit there-
after rats were euthanized and infarct and edema volume were calculated. Upper panel showing the representative photograph 
of TTC stained coronal section from brain sham-operated (a), peanut oil treated ischemic and (b) C.oil treated after ischemia 
(c). Number of animals used was ten in each group. Bar graph (d): Neurological evaluation scores of rats from sham-operated, 
peanut oil and C.oil post-treatment ischemic groups at 24 hrs are shown in scattergram. The line demarcates the median. *P < 
0.05 was considered significant when comparisons were made with the peanut oil treated ischemic group by Non parametric 
Kruskal-Wallis test followed by Dunn's Multiple Comparison Test. Bar graph (e): The bar chart showing the brain infarct vol-
ume after 24 hrs from sham-operated, peanut oil treated ischemic and C.oil post-treatment ischemic. Data are expressed as 
mean ± S.E.M. P < 0.001 was considered highly significant when comparisons were made with the peanut oil treated ischemic 
group by one way ANOVA followed by Newman Keuls post hoc test. Bar graph (f): Effect of post-treatment of C.oil on edema 
volume after 24 hrs of ischemia. Data are expressed as mean ± S.E.M. of ten animals each group. P < 0.001 was considered sig-
nificant when comparisons were made with the peanut oil treated ischemic group by one way ANOVA followed by Newman 
Keuls post hoc test.BMC Complementary and Alternative Medicine 2008, 8:55 http://www.biomedcentral.com/1472-6882/8/55
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Reactive oxygen species measurement
Rats of the peanut oil treated ischemic group showed an
increased level of ROS (Mean fluorescence 266.7 ± 11.7)
as compared to sham-operated animals (Mean fluores-
cence 15.0 ± 3). C.oil treated ischemic group showed sig-
nificant decrease in ROS content (Mean fluorescence 31.1
± 1.8) (P < 0.001) (Fig. 6b).
Intracellular calcium
Isolated neurons from the brain of peanut oil treated
ischemic rats after 24 hrs of clot implant showed signifi-
cantly increased level of calcium as compared to sham-
operated animals. C.oil treatment after 4 hrs of clot
implant showed significant decreases in calcium over-
load. (P < 0.001) There was no significant difference in the
calcium level of sham-operated group and C.oil treatment
group (Fig. 6c).
Peroxynitrite measurement
Significant increased level of peroxynitrite was observed
in peanut oil treated ischemic group as compared to
sham-operated group. C.oil treatment significantly
decreases the ischemia induced peroxynitrite content (P <
0.05) (Fig. 6d).
Mitochondrial membrane potential (ΔΨm)
An increase in fluorescence for ΔΨm was observed in pea-
nut oil treated ischemic group of brain neurons. The fluo-
rescence from C.oil post treatment neurons was close to
Brain tissue Nitrate/Nitrite levels were estimated at 6, 12 and 24 hrs after ischemia Figure 5
Brain tissue Nitrate/Nitrite levels were estimated at 6, 12 and 24 hrs after ischemia. Rats from sham-operated, 
peanut oil treated ischemic and C.oil treated groups were euthanized at 6, 12 and 24 hrs. At each time point five rats/group 
were used for the study. Data are expressed as mean ± S.E.M P < 0.001 was considered significant when comparisons were 
made with the peanut oil treated ischemic group by one way ANOVA followed by Newman Keuls post hoc test.(a): Nitrate 
levels and (b): Nitrite levels. (c): Effect of C.oil on myeloperoxidase (MPO) activity after 24 hrs of ischemia. Five rats per group 
from sham-operated, peanut oil treated ischemic and C.oil post treated were euthanized at 24 hrs Data are expressed as mean 
fluorescence ± S.E.M. Statistical significance was assessed by one way ANOVA. P < 0.001 was considered highly significant 
when comparisons were made between the peanut oil treated ischemic and the C.oil post-treatment group by Newman Keuls 
post hoc test. Neuroprotective effect of brain tissue caspase-3 (d): and caspase 1&4 (e): activity after 24 hrs of ischemia. Five 
rats each group from sham-operated, peanut oil treated ischemic and the treatment group with C.oil were euthanized at 24 
hrs. Data are expressed as mean fluorescence ± S.E.M. Statistical significance was assessed by one way ANOVA. P < 0.05 was 
considered significant when comparisons were made among different groups by Newman Keuls post hoc test.BMC Complementary and Alternative Medicine 2008, 8:55 http://www.biomedcentral.com/1472-6882/8/55
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Flowcytometric estimation of neuronal rich cell population from sham-operated, peanut oil treated ischemic and C.oil treated  groups were euthanized at 24 hrs Figure 6
Flowcytometric estimation of neuronal rich cell population from sham-operated, peanut oil treated ischemic 
and C.oil treated groups were euthanized at 24 hrs. Brain neuronal rich cell population were loaded with different 
fluorochromes for the estimation of neuronal Reactive Oxygen Species (ROS), Nitric oxide (NO), Peroxynitrite (ONOO-), 
mitochondrial membrane potential (ΔΨm), intracellular calcium level and quantification of cell death type. Mean fluorescence 
of neurons (106/ml) were acquired for quantification and analyzing in cell quest program of Becton Dickinson Flowcytometer. 
Data are expressed as mean fluorescence ± S.E.M P < 0.001 was considered highly significant when comparisons were made 
with the peanut oil treated ischemic group by one way ANOVA followed by Newman Keuls post hoc test. Five rats per group 
were used. (a): Nitric oxide from neurons (106/ml) were estimated using Diaminofluoresceindiacetate (DAF-2DA). (b): ROS 
were estimated from neurons (106/ml) using the mean fluorescence of DCDHF-DA. (c): Measurements of intracellular calcium 
from neurons (106/ml) were estimated using, fluorescence of Fluo-3AM. (d): Peroxynitrite was estimated from neurons (106/
ml) using the mean fluorescence of DHR 123. (e): For estimation of mitochondrial membrane potential the mean fluorescence 
of Rhod 123 obtained from neurons (106/ml). Lower panel: Representative dot plots for quantification of mode of death, the 
mean florescence, from neuron using FITC- conjugated Annexin V and Propidium iodide (PI). Neurons (106/ml) were obtained 
from sham-operated (f), peanut oil treated ischemic (g) and C.oil post-treatment ischemic (h) groups of rats; lower left quad-
rant shows viable cells (Annexin V negative and PI negative), lower right quadrant shows early apoptosis (Annexin V positive 
and PI negative, Upper right quadrant shows late apoptotic/necrotic cells (Annexin V positive and PI positive) and upper left 
quadrant shows necrotic cells (Annexin V negative and PI positive).BMC Complementary and Alternative Medicine 2008, 8:55 http://www.biomedcentral.com/1472-6882/8/55
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sham-operated. C.oil treatment offered significant protec-
tion as the fluorescence decreased (P < 0.001) (Fig. 6e).
Neuronal death
In peanut oil treated ischemia group significantly large
numbers of neurons were found apoptotic (45.37%) in
comparison to the other groups. C.oil post treatment
group showed reduction in cell death. The percentage of
viable cells was increased significantly (80.31%), with the
early apoptotic cells population reduced to 7.28% (Fig. 6
Lower panel).
Expression of iNOS, eNOS and cytochrome c
The microscope fields from midline to 2 mm lateral in the
neocortex of the right and left side of each brain section
were viewed. For some purposes, the usefulness of dual
labeling for iNOS, eNOS and cytochrome c  can be
extended by combining it with a second fluorescent
probe. For example, it can be combined with DAPI which
will label the nuclei of all viable cells. Negligible immu-
nostaining was detected for iNOS, eNOS and cytochrome
c in the sham-operated group, whereas they were strongly
expressed and some of these cell bodies were remarkably
shrunken with condensed and clumped nuclear chroma-
tin in the peanut oil treated ischemic group. Post admin-
istration of C.oil suppressed the iNOS (Fig. 7a), eNOS
(Fig. 8a) and cytochrome c (Fig. 9a) expression after 24
hrs of ischemia. This observation indicates that post-treat-
ment by C.oil inhibits the expression of the iNOS, eNOS
and cytochrome c.
Confirmation of these observations was done with the
help of western blot analysis C.oil post treatment signifi-
cantly decreased the ischemia induced expression of iNOS
Effect of C.oil on immunohistochemical and Western blot analysis iNOS expression after 24 hrs of ischemia in the brain Figure 7
Effect of C.oil on immunohistochemical and Western blot analysis iNOS expression after 24 hrs of ischemia in 
the brain.(a): Photomicrographs (representative of 5 photomicrographs) showing inducible nitric oxide synthase (iNOS) 
immunoreactivity in sham-operated group (A-C); peanut oil treated ischemia group (D-F), and ischemia-C.oil post-treated 
groups (G-I) after 24 hrs of clot implant. Sections were immunolabeled with a polyclonal anti-iNOS antibody, which was 
observed as green fluorescence (B, E & H) and counterstaining by DAPI is shown as blue fluorescence (A, D & G). The merger 
is shown in C, F & I. Magnification: 40×. (b) iNOS expression by immunoblotting. Bar chart shows the quantification of bands. 
Lower Panel showing the representative bands for iNOS and β-Actin as lane 1: sham-operated, lane 2: Peanut oil treated 
ischemic, and lane 3: C.oil post treated (50 μg/lane). Data are expressed as mean ± S.E.M of five animals per group. (*P < 0.05) 
was considered highly significant when comparisons were made with the peanut oil treated ischemic group by one way 
ANOVA followed by Newman Keuls post hoc test.BMC Complementary and Alternative Medicine 2008, 8:55 http://www.biomedcentral.com/1472-6882/8/55
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(Fig. 7b) and eNOS (Fig. 8b) when compared with peanut
oil treatment ischemic group after 24 hrs. The cytochrome
c release was observed in peanut oil treated ischemic brain
tissue. A significant decrease in the cytochrome c expres-
sion was observed from C.oil treated brain as compared to
ischemic peanut oil treated rats (Fig. 9b).
Expression of Bax and Bcl-2
Significant increase in the expression of Bax was observed
in peanut oil treated ischemic group after 24 hrs. Expres-
sion was reduced in the C.oil post treatment group and
was almost equal to sham-operated group (Fig. 10a). Sig-
nificant decrease in the expression of Bcl-2 was observed
in peanut oil treated ischemic group after 24 hrs. Expres-
sion was increased in the C.oil treatment group but was
not equal to that in the sham-operated group (Fig. 10b).
Discussion
The studies presented above show that C.oil significantly
reduces infarct size and improves neuroscore after
ischemic insult induced by MCAo rats. Moreover, C.oil
treatment confers a large therapeutic window of at least 4
hours and is devoid of major hemorrhagic risk.
After an ischemic attack, brain infarction tends to spread
out circumferentially from the core of the infarct and the
penumbral regions undergo delayed energy-dependent
apoptosis [34] and inflammation [35]. In particular,
thromboembolic stroke develops in a very complicated
manner; on the one hand, the ischemic lesion may
enlarge over the period of time and may result in a large
infarct. On the other hand, in a situation where spontane-
ous reperfusion can occurs, the brain tissue may be sal-
Effect of C.oil on immunohistochemical and Western blot analysis of eNOS expression after 24 hrs of ischemia in the brain Figure 8
Effect of C.oil on immunohistochemical and Western blot analysis of eNOS expression after 24 hrs of ischemia 
in the brain.(a): Endothelial nitric oxide synthase immunoreactivity after 24 hrs of ischemia. Photomicrographs (representa-
tive of 5 photomicrographs) showing endothelial nitric oxide synthase (eNOS) immunoreactivity in sham-operated group (A-
C); peanut oil treated ischemia group (D-F), and ischemia-C.oil post-treated groups (G-I) after 24 hrs of clot implant. Sections 
were immunolabeled with a polyclonal anti-eNOS antibody, which was observed as green fluorescence (B, E & H) and counter-
staining by DAPI is shown as blue fluorescence (A, D & G). The merger is shown in C, F & I. Magnification: 40×. (b) eNOS 
expression by immunoblotting. Bar chart shows the quantification of bands. Lower Panel showing the representative bands for 
eNOS and β-Actin as lane 1: sham-operated, lane 2: Peanut oil treated ischemic, and lane 3: C.oil post treated (50 μg/lane). 
Ischemia induced eNOS expression was greatly reduced by C.oil post treatment. Data are expressed as mean ± S.E.M of five 
animals per group. (*P < 0.01) was considered highly significant when comparisons were made with the peanut oil treated 
ischemic group by one way ANOVA followed by Newman Keuls post hoc test.BMC Complementary and Alternative Medicine 2008, 8:55 http://www.biomedcentral.com/1472-6882/8/55
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vaged [36]. There are many reports of qualitative, but not
quantitative, changes in lesion volume in thromboem-
bolic stroke in individual rats [37]. Therefore, we designed
the present study to examine how lesion volume and inf-
arct volume after thromboembolism evolves quantita-
tively. We were unable to observe a significantly reduction
in the early lesion (MRI). A significant attenuation was
observed in volume of infarct (TTC) by C.oil treatment at
5 hrs and 24 hrs after ischemia.
Behavioral testing, in addition to histology over 5 hrs to
24 hrs after ischemia adds to the reliable evaluation of
potential therapeutic interventions after embolic MCA
occlusion. Assessment of functional outcome more
closely reflects the approach in human clinical studies on
re-canalization. Furthermore, relying only on infarct vol-
ume does not show the detection of abnormal function
after ischemia in cases of normal or near-normal histol-
ogy. An improvement in the neurological score was
observed with C.oil treatment.
Brain edema formation, is one of the most dangerous con-
sequences of ischemic brain injury [38]. An important fac-
tor of brain edema formation is the toxicity due to free
radicals generated from lipid peroxidation. We have
observed significant suppression in edema volume (as
judged by hemispheric enlargement). This is an interest-
ing finding, indicating that the anti-edematous effects of
C.oil persisted for at least 24 hrs from a therapeutic point
of view, this can be extremely useful. This effect of C.oil
Effect of C.oil on immunohistochemical and Western blot analysis cytochrome c expression after 24 hrs of ischemia in the  brain Figure 9
Effect of C.oil on immunohistochemical and Western blot analysis cytochrome c expression after 24 hrs of 
ischemia in the brain. (a): Cytochrome c immunoreactivity after 24 hrs of ischemia. Photomicrographs (representative of 5 
photomicrographs) showing inducible nitric oxide synthase (iNOS) immunoreactivity in sham-operated group (A-C); peanut oil 
treated ischemic group (D-F) and C.oil post-treated groups (G-I) after 24 hrs of clot implant. Sections were immunolabeled 
with a polyclonal anti-cytochrome c antibody, which was observed as green fluorescence (B, E & H) and counterstaining by 
DAPI is shown as blue fluorescence (A, D & G). The merger is shown in C, F & I. Magnification: 40×. (b) Cytochrome c expres-
sion by immunoblotting. Bar chart shows the quantification of bands. Lower Panel showing the representative bands for cyto-
chrome c and β-Actin as lane 1: sham-operated, lane 2: Peanut oil treated ischemic, and lane 3: C.oil post treated (50 μg/lane). 
Ischemia induced cytochrome c expression was greatly reduced by C.oil post treatment. Data are expressed as mean ± S.E.M 
of five animals per group. (*P < 0.01) was considered highly significant when comparisons were made with the peanut oil 
treated ischemic group by one way ANOVA followed by Newman Keuls post hoc test.BMC Complementary and Alternative Medicine 2008, 8:55 http://www.biomedcentral.com/1472-6882/8/55
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may be due to scavenging of free radicals and the preven-
tion of lipid peroxidation as reported earlier in our report
[6,14]. An important question that has not been
addressed in the present study is the molecular mecha-
nism of C.oil's anti-edema action.
Chemotactic recruitment of leukocytes starts within hours
of I/R insult and these adhere to the internal lumen of
blood capillaries. On the one hand, activated leukocytes
produce a secondary occlusion and, on the other hand,
generate a burst of significant amount of superoxide add-
ing to the injury. The tissue MPO levels were significantly
attenuated by post treatment with C.oil.
NO-induced apoptosis has been studied in a variety of cell
types, and a direct action of NO on the mitochondria,
leading to collapse of mitochondrial membrane potential
followed by cytochrome c release, has been suggested as
the major mechanism [39]. Accordingly, we elected to
study the possible effect of NO metabolites, on the mito-
chondrial membrane potential and cytochrome c release.
Cytochrome c release was followed by the activation of
caspase-9 and -3, we next wanted to elucidate whether the
pattern of activation of the caspases could be correlated to
the pattern of cytochrome c release. There is also disagree-
ment as to the specific role of some of these pathways [40]
and the complex interactions ('cross-talk') that exist
between these pathways.
In it perhaps relevant to mention in this context, that the
initial rise in NO starts within 3–24 min and rises signifi-
cantly from <10 nM upto1 μM during ischemia [41] due
to activation of constitutive NOS. In the extra cellular
milieu, NO reacts with oxygen and water to form nitrates
and nitrites. In the present study, NOx  levels in the
ischemic brain were increased, consistent with reports
from other laboratories [42] and in patients following
stroke [43]. The delayed increase in NOx levels in the brain
Effect of C.oil on Western blot analysis of Bax and Bcl-2expression after 24 hrs of ischemia in the brain Figure 10
Effect of C.oil on Western blot analysis of Bax and Bcl-2expression after 24 hrs of ischemia in the brain.(a) Bax 
expression by immunoblotting. Bar chart shows the quantification of bands. Lower Panel showing the representative bands for 
Bax and β-Actin as lane 1: sham-operated, lane 2: Peanut oil treated ischemic, and lane 3: C.oil post treated (50 μg/lane). 
Ischemia induced Bax expression was greatly reduced by C.oil post treatment. Data are expressed as mean ± S.E.M of five ani-
mals per group. *P < 0.05 was considered highly significant when comparisons were made with the peanut oil treated ischemic 
group by one way ANOVA followed by Newman Keuls post hoc test. (b) Bcl-2 expression by immunoblotting. Bar chart shows 
the quantification of bands. Lower Panel showing the representative bands for Bcl-2 and β-Actin as lane 1: sham-operated-
operated, lane 2: Peanut oil treated ischemic, and lane 3: C.oil post treated (50 μg/lane). Ischemia induced Bcl-2 expression was 
greatly increased by C.oil post treatment. Data are expressed as mean ± S.E.M of five animals per group. (*P < 0.05) was con-
sidered highly significant when comparisons were made with the peanut oil treated ischemic group by one way ANOVA fol-
lowed by Newman Keuls post hoc test.BMC Complementary and Alternative Medicine 2008, 8:55 http://www.biomedcentral.com/1472-6882/8/55
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tissue after cerebral ischemia may be injurious or, at the
very least, reflect injury. C.oil blunts the detrimental rise
in NOx at after ischemic injury. It is more pertinent to
consider the formation of peroxynitrite due to the lack of
availability of NO and ROS. C.oil reduces the production
of NO and ROS. In the present study, the ischemic
induced decrease in functional capacity of the neuronal
mitochondria was ascertained by probing the mitochon-
drial membrane potential (Δψm) with Rhd 123. Under
the conditions of the present study, the increase in total
fluorescence of Rhd 123 indicated the probable depolari-
zation or collapse of the mitochondria within the neu-
rons. Post treatment with C.oil prevents the increase in the
fluorescence indicating a protection of the membrane
potential or no depolarization of the mitochondria within
the neurons. On one hand the ischemia damage to the
mitochondrial respiratory chain may cause increase in
mitochondrial generation of ROS and on other substan-
tial rise in cytosolic calcium promotes the mitochondrial
calcium uptake causing the collapse of (Δψm). C.oil treat-
ment reduces the neuronal ROS and calcium rise.
We have reported recently that pretreatment by C.oil was
significantly effective in limiting brain injury in an in vivo
model of cerebral ischemia/reperfusion (the middle cere-
bral artery occlusion in rats) where the role of oxidative
stress is highly implicated [6,14]. We further observed a
significant rise is peroxynitrite levels as previously
reported. C.oil attenuated this rise significantly. A rise in
peroxynitrite levels can induce apoptosis cell death in
ischemic injury [44]. If so, peroxynitrite-mediated apop-
totic may also be inhibited by C.oil.
Interestingly, the resultant effect of ischemia on the neu-
ronal calcium overload was significantly reduced by C.oil.
However, it is important to mention that, in addition to
interacting with calcium, C.oil has other properties that
may also contribute to neuroprotection. During ischemia
eNOS expression is augmented, while nNOS increases
during reperfusion. It has been suggested that eNOS-
derived NO may protect against ischemia by contributing
to vasodilatation and by inhibiting aggregation and
adherence of platelets or leukocytes [45]. It is not clearly
evident whether endothelial NOS or neuronal NOS, or
both caused the elevation of the NO end products seen
after ischemic insults. After a transient increase in the
expression of both nNOS and eNOS in the ischemic area,
a secondary wave of NO overproduction starts to develop
several hours after the initial ischemic insult and is sus-
tained for up to 4–7 days [46,47] iNOS expression is
much more variable in experimental stroke, as it may start
around 4 hrs after MCAo [48] and 12 hrs after ischemia/
reperfusion insult in transient forebrain ischemia model
[49].
When iNOS expression rises, NO production naturally
starts to rise. Greater NOS activity in core regions could
explain in part the increased vulnerability of that region to
ischemic damage and could theoretically contribute to the
progression of the infarct over time [50]. Our data sug-
gests neuroprotection shown by C.oil could primarily be
due to inhibition of iNOS because we have administered
the C.oil 4 hrs after initial ischemic insult. Previous stud-
ies have shown that expression of iNOS starts after 4–6 hrs
after of initial ischemic insult. This observation was fur-
ther substantiated by highly significant rise in NOx levels.
It is well documented that expression of nNOS peaks after
1 hr of initial ischemic insult so at the time of treatment
this target is already lost.
Increased expression of caspase-1, -3, -8, and -9, and of
cleaved caspase-8, has been reported in the penumbra.
Our results, together with the data available in literature
suggest the neuroprotective effect of Caspase-1. It has the
peculiarity of being involved in the activation of both
apoptosis and inflammation, through the intermediation
of the pro-inflammatory cytokine IL-1b [51]. Although
our data demonstrated attenuation of caspase-1&4 and 3
by C.oil in transient focal cerebral ischemic injury, we do
not exclude a role for cytokines in the regulation of cell
death.
One of the other mechanism(s) by which the release of
cytochrome  c  occurs is mediated by the Bcl-2 family,
including Bax and Bid, which promote apoptosis, whereas
the antiapoptotic members of the Bcl-2 family of proteins,
including Bcl-2 and Bcl-xL, prevent the release of cyto-
chrome c from the mitochondria [52]. Moreover, NO-
induced apoptosis is related to the increase in the Bax/Bcl-
xL rate, the release of cytochrome c and caspase activation
[53]. We, therefore, studied the possible role of Bax and
Bcl-2. Bax translocation to the mitochondria occurs in
response to a wide variety of apoptotic stimuli and may,
therefore, serve as a key interaction point for various
apoptotic signals.
C.oil attenuates the up-regulation of Bax and up-regulates
Bcl-2 expression; these possibly block the release of mito-
chondrial cytochrome c  and prevent apoptosis. C.oil
might thereby modify biochemical pathways that lead to
cell death or survival. Perhaps action of C.oil in control-
ling both apoptosis and necrosis through up or down reg-
ulation of various pathways is advantageous as a way to
ensure immediate and complete elimination of damaged
cells. A complex cascade of molecular events is set in
motion during cerebral ischemia and culminates in neu-
ronal cell death some of major events are shown in Fig.
11.BMC Complementary and Alternative Medicine 2008, 8:55 http://www.biomedcentral.com/1472-6882/8/55
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Conclusion
In brief, C.oil significantly reduces the ill effect of
ischemia by attenuating nitrosative and oxidative stress.
Ischemia induces collapse of mitochondrial membrane
potential, cytochrome c  release, altering the Bax: Bcl-2
ratio and subsequently caspases activation led to induc-
tion of apoptosis in sequential fashion was reverse signif-
icantly by C.oil post treatment. In conclusion, our
findings provide evidence for the high efficacy of C.oil as
a neuroprotective, with an excellent therapeutic window
for the prevention of ischemic brain injury.
It remains an open question whether C.oil would also
have neuroprotective effects in humans, but careful study
in these aspects seem warranted. Recently C.oil is reported
for reversing oral sub mucosal fibrosis; a precancerous
condition for oral cancer, is well tolerated and has been
recommended for a Phase II trial in patients [54].
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Schematic diagram showing some of important downstream targets of apoptosis, as well as necrosis Figure 11
Schematic diagram showing some of important downstream targets of apoptosis, as well as necrosis. Neuro-
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